Dynamic Technology Lab’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,929
Closed -$330K 1621
2020
Q4
$330K Buy
17,929
+4,181
+30% +$76.2K 0.05% 611
2020
Q3
$252K Buy
+13,748
New +$231K 0.04% 729

Dynamic Technology Lab's CBMG Position: Q1 2021 in Review

Dynamic Technology Lab sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 17,929 shares — an estimated $330K sold.

Dynamic Technology Lab first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $330K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Dynamic Technology Lab reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,929 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $330K.
  • Dynamic Technology Lab first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Dynamic Technology Lab's Cellular Biomedicine Group, Inc. position peaked at $330K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Dynamic Technology Lab's 13F filing for Q1 2021, filed 14 May 2021.